Comera Life Sciences Holdings, Inc. (CMRA)
OTCMKTS: CMRA · Delayed Price · USD
0.0300
0.00 (0.00%)
May 2, 2024, 1:39 PM EDT - Market closed

CMRA Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202220212020
Net Income
-24.04-5.29-2.13
Depreciation & Amortization
0.090.090.09
Share-Based Compensation
0.381.110.1
Other Operating Activities
13.80.330.13
Operating Cash Flow
-9.77-3.76-1.8
Capital Expenditures
-0.03-0.14-0.01
Investing Cash Flow
-0.03-0.14-0.01
Common Stock Issued
0.8301.39
Share Repurchases
65000
Other Financing Activities
654.4110.280.16
Financing Cash Flow
5.2410.281.55
Net Cash Flow
-4.566.38-0.26
Free Cash Flow
-9.8-3.9-1.82
Free Cash Flow Margin
-1547.99%-1219.38%-410.11%
Free Cash Flow Per Share
-0.94-0.20-0.10
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.